• Home
  • MF Research
  • Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW Reinvestment

Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW Reinvestment

arrow-down
NAV
₹ 11.2493 ₹ -0.4 (-3.53 %)
as on 07-04-2025
Asset Size (AUM)
119 Cr
Launch Date
Apr 26, 2024
Investment Objective
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
Minimum Investment 0.0
Minimum Top-up 0.0
Investment Returns Since Launch in Apr 26, 2024
arrow-up

11.6

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.0 %
Expense Ratio
1.1%
Volatility
0.0 %
Fund House
Tata Mutual Fund
Fund Manager
Kapil Menon
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 0.0 (plus in multiples of Rs. 0.0)

Entry Load
Not applicable
Exit Load
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFD
Fund₹ 10000
FD₹ 10600
Performance

Scheme Performance (%)

Data as on - 07-04-2025
Created with Highcharts 4.1.4ReturnsTata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW ReinvestmentNIFTY 100 Equal Weight TRIIndex FundYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-2002040

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesTata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW ReinvestmentNIFTY 100 Equal Weight TRIIndex Fund2016201720182019202020212022202320242025-40-200204060
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund120,000116,426-3,574-6.45
Benchmark110,000102,211-7,789-14.08
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Portfolio Analysis
Portfolio as on 28-02-2025
Sector Allocation
SectorAllocation (%)
Healthcare100.08
Portfolio Holdings
CompanyHoldings (%)
MAX HEALTHCARE INSTITUTE LIMITED EQ14.84
LUPIN LIMITED EQ NEW F.V. RS.2/-9.38
FORTIS HEALTHCARE LIMITED. EQ6.52
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-6.04
ALKEM LABORATORIES LIMITED EQ5.04
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-4.86
LAURUS LABS LIMITED EQ NEW FV RS. 2/-4.24
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-3.93
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-3.76
ABBOTT INDIA LIMITED EQ3.23
SUVEN PHARMACEUTICALS LIMITED EQ3.15
BIOCON LIMITED EQ2.78
Krishna Institute Of Medical Sciences Limited2.61
GLAND PHARMA LIMITED EQ NEW FV Re.1/-2.52
SYNGENE INTERNATIONAL LIMITED EQ2.41
JB Chemicals & Pharmaceuticals Limited2.4
PIRAMAL PHARMA LIMITED EQ2.39
AJANTA PHARMA LIMITED EQ NEW FV RS. 2/-2.14
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ2.09
NARAYANA HRUDAYALAYA LIMITED EQ2
GLOBAL HEALTH LIMITED EQ1.95
ASTER DM HEALTHCARE LIMITED EQ1.8
DR. LAL PATHLABS LIMITED EQ NEW FV RS. 10/-1.76
POLY MEDICURE LIMITED EQ NEW FV RS. 5/-1.58
NATCO PHARMA LIMITED EQ NEW FV RS. 2/-1.41
GRANULES INDIA LIMITED EQ NEW FV RE. 1/-1.37
RAINBOW CHILDRENS MEDICARE LIMITED EQ1.26
SANOFI INDIA LIMITED EQ0.93
ALEMBIC PHARMACEUTICALS LIMITED EQ0.85
METROPOLIS HEALTHCARE LIMITED EQ NEW FV RS. 2/-0.84
A) REPO0.16
Sector Allocation
Created with Highcharts 4.1.4Others
Portfolio Holdings
Created with Highcharts 4.1.4MAX HEALTHCARE INSTITUTE LIMITED EQLUPIN LIMITED EQ NEW F.V. RS.2/-FORTIS HEALTHCARE LIMITED. EQAUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-ALKEM LABORATORIES LIMITED EQMANKIND PHARMA LIMITED EQ NEW FV RE. 1/-LAURUS LABS LIMITED EQ NEW FV RS. 2/-GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-Others